Home
  • About Us
  • Magazines
  • Our Events
  • Services
  • Science Watch
  • Events Calendar
  • Useful Websites
  • Login / Register
  • Head Office

sp2 News

SOCMA reiterates call for risk-based approach to TSCA reform

For the second time in less than four months, the Society of Chemical Manufacturers and Affiliates (SOCMA) testified before the US Congress on reforming chemical safety laws, arguing again in favour of a risk-based approach to chemicals management.

Last updated: 
March 10
»
  • Read more

more stories...

  • Exelixis announces restructuring and reduces workforce by 40 per cent
  • FDA Advisory Committee recommends approval of InterMune idiopathic pulmonary fibrosis drug
  • BIA welcomes Dyson recommendations on R&D tax credits
  • Roche and Biogen Idec suspend Ocrelizumab RA programme
  • Pluristem Therapeutics receives approval to advance cell therapy product to final dose level
  • Ark withdraws Cerepro MAA to examine EMEA recommendation
  • Watson confirms filing of generic pain treatment application
  • SpePharm forms strategic partnership with Paladin Labs and receives new financing
  • Biolin Scientific acquires Farfield Group
  • Gentronix signs three-year genotoxicity assays agreement with GSK
  • ClinTec and HCG collaborate in clinical trials services

Welcome to sp2 Magazine

As the premier European based drug discovery, development and delivery publication, sp2 Magazine is committed to providing an outstanding information platform for the international pharmaceutical and biotech community.

We bring organisations in discovery biology, discovery chemistry, contract research, contract manufacture, pharmaceutical and biopharmaceutical drug manufacturing, and drug formulation and delivery together through our information portals which provide the latest news, research and analysis on what's happening today and what it means for your business tomorrow.

All technical articles published in
sp2 Magazine since 2007 are now available for you to access. Simply enter key words now to find the articles of most interest to you.

You can also search archived sp2 News.

Featured sponsors:

sp2 Magazine

  • Home
  • Editorial Calendar
  • Advertising Opportunities
  • Digital Magazine
  • Contact the Editor

Tom's Blog

  • On the road to recovery?
  • Mixed fortunes in life sciences
  • Do you trust the politicians?
  • Ensuring the guidelines are right
  • Looking after the smaller companies in life sciences
  • Getting the best for biotech
more
Follow us on Twitter
Syndicate content - RSS Feed
Picture OnePicture TwoPicture ThreePicture FourPicture Five




(c) 2009, 2010 avakado Limited All Rights Reserved - Privacy & Legal
Site created and maintained by Siric Communications